Taxanes (docetaxel and paclitaxel) are among the most commonly prescribed anticancer
drugs approved for the treatment of metastatic or locally advanced breast, non-small cell …

Drug reactions resulting from chemotherapy agents are common and frequently affect the
skin. Although often benign, a select few of these cutaneous reactions may necessitate …

Bortezomib is the first proteasome inhibitor to treat a variety of malignancies and is currently
part of the standard of care regimen for the initial treatment of patients with newly diagnosed …

Serpentine supravenous hyperpigmentation (SSH) describes increased skin pigmentation
that develops in the area immediately overlying the vessels through which …

Serpentine erythematous or hyperpigmented streaks along the superficial venous network
proximal to the site of injection may occur as a distinctive eruption after infusion of several …

Serpentine supravenous hyperpigmentation (SSH) is a unique type of chemotherapy‐
associated drug eruption, characterized by hyperpigmentation along the superficial venous …

Background Serpentine supravenous hyperpigmentation (SSH) is known as a phenomenon
occurring during the infusion of chemotherapy agents in the underlying veins …

Résumé L'apparition d'une hyperpigmentation au cours des chimiothérapies est un des
effets indésirables dermatologiques les plus fréquemment constatés avec ces traitements …

Opinion statement In recent years, oncogene-directed targeted agents and
immunotherapies have expanded the treatment armamentarium for advanced lung cancer …

A 42-year-old woman being treated with 5-fluorouracil for carcinoma of the sigmoid colon
developed persistent serpentine supravenous hyperpigmented eruption (PSSHE), bilateral …